HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY: ifrs:DilutedEarningsLossPerShare

Value{"amount": 0.836}
Period2022-01-01 – 2022-12-31
Statuscurrent
EntityHIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:549300BNS685UXH4JI75:2022-12-31
Retrieved: 2026-08-24T01:10:56.716994+02:00
Raw response sha256: 7bef655a84e92333bdbe1738523ea5a9…
Cite as: FACTANKER, https://factanker.com/fact/29a09a8c-cbbb-4ca7-9186-238252733ff4

History